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Abstract
Background: Developmental, physiological and tissue engineering studies critical to the development of successful
myocardial regeneration therapies require new ways to effectively visualize and isolate large numbers of fluorescently
labeled, functional cardiomyocytes.
Methodology/Principal Findings: Here we describe methods for the clonal expansion of engineered hESCs and make
available a suite of lentiviral vectors for that combine Blasticidin, Neomycin and Puromycin resistance based drug selection
of pure populations of stem cells and cardiomyocytes with ubiquitous or lineage-specific promoters that direct expression
of fluorescent proteins to visualize and track cardiomyocytes and their progenitors. The phospho-glycerate kinase (PGK)
promoter was used to ubiquitously direct expression of histone-2B fused eGFP and mCherry proteins to the nucleus to
monitor DNA content and enable tracking of cell migration and lineage. Vectors with T/Brachyury and a-myosin heavy chain
(aMHC) promoters targeted fluorescent or drug-resistance proteins to early mesoderm and cardiomyocytes. The drug
selection protocol yielded 96% pure cardiomyocytes that could be cultured for over 4 months. Puromycin-selected
cardiomyocytes exhibited a gene expression profile similar to that of adult human cardiomyocytes and generated force and
action potentials consistent with normal fetal cardiomyocytes, documenting these parameters in hESC-derived
cardiomyocytes and validating that the selected cells retained normal differentiation and function.
Conclusion/Significance: The protocols, vectors and gene expression data comprise tools to enhance cardiomyocyte
production for large-scale applications.
Citation: Kita-Matsuo H, Barcova M, Prigozhina N, Salomonis N, Wei K, et al. (2009) Lentiviral Vectors and Protocols for Creation of Stable hESC Lines for
Fluorescent Tracking and Drug Resistance Selection of Cardiomyocytes. PLoS ONE 4(4): e5046. doi:10.1371/journal.pone.0005046
Editor: Mikhail V. Blagosklonny, Ordway Research Institute, United States of America
Received October 22, 2008; Accepted February 17, 2009; Published April 8, 2009
Copyright:  2009 Kita-Matsuo et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was funded by grant support from the California Institute for Regenerative Medicine (CIRM) (RC1-00132-1) and NIH (R37HL059502,
R33HL088266) to MM; the Mather’s Charitable Foundation to MM and JHP; an Early Career Development Award from American College of Cardiology Foundation
(ACCF), Bechtel Trusts & Foundation Grant, and CIRM (RS1-00171-1) to H-S.V.C.; NIH (HG003053 and HL66621) to BRC; and NIH (5P01HL46345-12) to ADM and
University of California Biotechnology, Research and Education Program (UCBREP) GREAT award (2006-016) to ADM and KW. The funders had no role in study
design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: mmercola@burnham.org
¤ Current address: Department of Chemical and Systems Biology, Stanford University, Stanford, California, United States of America
Introduction
The minimal ability of the adult human heart to regenerate lost
or damaged cardiomyocytes has led to an intense effort to direct
human embryonic stem cells (hESCs) to form cardiomyocytes in
order to model human heart disease and develop therapies [1].
hESC-derived cardiomyocytes resemble immature human fetal
cardiomyocytes by multiple criteria, including electrophysiology
[2,3], calcium handling [3,4,5], force generation [5], and
contractile protein expression and myofibrillar structure [6]. Since
hESC-derived cardiomyocytes have the potential to engraft into
surgical models of heart disease [7,8], they have been considered
for cardiomyocyte replacement therapy and as well as a tool to
discover drugs capable of stimulating endogenous regeneration.
Despite such encouraging advances, the application of hESC-
derived cardiomyocytes for basic developmental research and
large-scale applications, such as high throughput screening,
toxicology testing and large animal studies, has been hindered
by their poor yield from the heterogeneous hESC cultures and the
difficulty of manipulating hESCs to express uniform levels of
reporter constructs. We have therefore developed methods and
vectors to produce homogeneous hESC lines with fluorescent and
PLoS ONE | www.plosone.org 1 April 2009 | Volume 4 | Issue 4 | e5046drug-selectable markers that permit isolation of pure populations
of labeled stem cells and hESC-derived cardiomyocytes.
Prior strategies to increase the yield of cardiomyocytes from
hESCs have included optimizing culture regimens by the addition
of growth factors and other reagents to direct differentiation
[7,9,10]. Although such advances quantitatively improved the
proportion of the cells that differentiate into cardiomyocytes, in
most settings the yield remains between 5–25%. Strategies for
enrichment have included manual dissection of beating areas
[10,11], PercollH density gradient sedimentation [7,12], and
fluorescence activated cell sorting (FACS) of cells based on
expression of a fluorescent reporter protein from cardiomyocyte
gene promoters [11,13]. Each of these strategies has drawbacks in
terms of purity (density gradient sedimentation and manual
dissection), viability (FACS) and scalability (FACS and manual
dissection). In theory, an effective alternative is drug resistance
based selection of cardiomyocytes as successfully implemented by
Field and collaborators using the Neomycin analogue G418 to
purify cardiomyocytes from differentiating mouse ESC cultures
[14]. Genetic selection has recently been adapted to hESCs [15],
and we applied this technology with a suite of lentiviral vectors and
protocols for the production of stable, homogenous and clonal
lines of hESCs with Neomycin, Blasticidin and Puromycin
resistance cassettes for drug selection of undifferentiated stem cells
and functional hESC-derived cardiomyocytes. Additional vectors
were constructed to produce hESC lines with eGFP and mCherry
fluorescent reporters of mesoderm and cardiac lineages and also
fluorescent Histone2B (H2B) fusion proteins that allow real-time
sensing of the DNA content and recognition by automated
algorithms for cell screening and tracking. We used 3 criteria
(electrophysiological characterization of action potentials, force
generation, and gene expression profile) to validate that the
isolation procedure did not adversely affect the cardiomyocytes,
indicati that the drug-isolated cardiomyocytes were physiologically
normal.
Results
Isolation of homogeneous lines of reporter hESCs
Lentiviral infection of hESCs commonly results in functional
transgene expression in only a fraction of the total cells, even at
high multiplicity of infection, illustrated by the typically mixed
colony of mCherry-labeled and unlabeled hESCs (Figure 1B) 7
days after lentiviral infection to express an H2BmCherry fusion
protein from a phosphoglycerate kinase promoter (PGK, dia-
grammed in Figure 1A). Undifferentiated hESCs are apparent as
flat colonies (Figure 1B) against the mouse embryo fibroblast
(MEF) feeder cells in the co-culture (see Methods). We also found
that expansion of mixed populations often reduces the percentage
of expressing cells (not shown), possibly reflecting expression from
non-integrated provirus, transgene silencing or a growth disad-
vantage of cells with the H2B fusion proteins. For example,
unsorted PGK H2BmCherry or H2BeGFP hESCs progressively
lose expression, beginning with as many as 80–90% positive cells
and declining to fewer than 5% by the 6
th passage and only a few
fluorescent cells after the 7
th passage (not shown). A further
problem with heterogeneous populations is that expression level of
transgene reporters tends to be varied, for example as reported for
cardiomyocyte-specific expression of eGFP [11,13], possibly
reflecting variable influences of chromatin surrounding the diverse
genome integration sites. The preparation of homogeneous, and
ideally clonal, populations would be expected to minimize
variability and therefore be desirable if not essential for many
quantitative or high throughput applications. Accordingly, we
found that FACS-enriched PGK-H2BmCherry- and PGK-
H2BeGFP-positive hESCs could be readily expanded and yielded
non-clonal cell lines that typically showed fairly uniform
fluorescence intensity when examined visually (Figure 1C). The
FACS-enriched hESCs could be maintained for at least 20
passages without loss of fluorescence. FACS-enriched H2B
fluorescent fusion protein hESCs retained the ability to form
cardiomyocytes when differentiated in embryoid body (EB) culture
(Figure 2A and Supplemental Movie S1).
Nuclear localized fluorescent proteins are useful for cell tracking.
Moreover, a label that shows a temporal change, such as correlation
with DNA content, can be used in correction routines for during
automatedtracking[16],forinstancetodistinguishtracksoftwocells
that cross paths from two daughters arising from a single progenitor.
To test utility of the nuclear fluorescent proteins in tracking
applications, differentiating cells of the FACS-enriched hESCs were
tracked automatically using a modified version of the Particle
TrackingPluginforImageJ [17].Fig.2Cshowsthe resultsofanalysis
of time-lapse image stacks of H2BmCherry fluorescence at the
border of a day 4 EB acquired at 10 minute intervals over a 20 hour
period using a 106objective and MetaMorph software (Methods).
Figure 2D and Supplemental Movie S2 show examples of individual
tracks of H2BmCherry centroids.
Comparison of the integrated fluorescence intensity of
H2BmCherry to that of DAPI in the overall population after
end-point fixation and flow cytometry yielded a squared
correlation coefficient (R
2) of 0.733, indicating that H2BmCherry
brightness is not as accurate a measure of DNA content as is DAPI
staining. Nonetheless, we examined whether the H2B fluorescent
fusion proteins could be used to report DNA content in real time
Figure 1. Lentiviral transduction and FACS enrichment of
hESCs. (A) Lentiviral constructs used in this study. Structural details are
provided in Supplemental Figures S3, S4, S5, S6, S7, S8, S9, S10 and
Methods. (B,C) Merged brightfield phase contrast micrographs of
mCherry-positive cells overlayed with fluorescence images illustrate the
variegated expression in a colony before (b) and reduced variability
after (c) FACS enrichment (see Materials and Methods). hESCs were
maintained on unlabeled MEFs.
doi:10.1371/journal.pone.0005046.g001
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undifferentiated hESC colony for a period of 2 days and analyzing
the levels of fluorescence intensity during instances of cell division
(Figure 2B). The integrated nuclear fluorescence intensity of
individual H2BmCherry-positive hESCs decreased 2-fold upon
cell division (Figure 2B). Thus, although cell-to-cell and temporal
variation were observed in the fixed endpoint and tracking data
[note that some immediate-post-division daughters exhibited
larger differences in H2BmCherry brightness (blue traces) than
others (grey, green and red)]; the temporal trends of single cells
during S-phase and division yield cell cycle information that might
be useful for error correction routines in automated tracking [16].
Method for clonal expansion of engineered hESC lines
In order to create homogeneous populations of fluorescent
reporter lines for quantitative applications, such as for high
throughput biology or for using biosensors to measure intracellular
signaling activity or subcellular constituents, we developed a
protocol for clonal expansion of single cells (Figure 3A). Plating of
hESCs at low seed density, such as limiting dilution for cloning,
typically triggers spontaneous differentiation that leads to a loss of
pluripotent cells [18]. The Rho-associated kinase inhibitor, Y-
27632, has been shown to alleviate the apoptosis associated with
dispersed hESCs [19]. As an additional solution to this problem,
we developed a straightforward method involving seeding of
Figure 2. Nuclear labeling and DNA content tracking with Histone-2B fluorescent fusion protein. (A) Fluorescence and brightfield
micrographs showing uniform PGK-H2BeGFP fluorescence in nuclei of cardiomyocytes derived from a FACS-enriched stable line. Spontaneous
contractile activity is apparent in Supplemental Movie S1. H2B eGFP expression correlated with DAPI by flow cytometry (R
2=0.733, see text). (B)
Examples of tracking of PGK-H2BmCherry hESCs cells, also from a FACS-enriched stable line, undergoing cytokinesis at the border of an
undifferentiated colony. Lower left inset shows fluorescence intensity of 10 images before and 10 images after cell division of the individual cells in
the larger figure (n=5). Upper right inset shows heatmap representation of H2BmCherry fluorescence intensity of a single dividing cell. (C) Tracks
calculated automatically using ImageJ Plugin [17] from time-lapse images of H2BmCherry fluorescence at the border of undifferentiated ESC colony
over a 2 day period (Methods). Yellow boxes indicate frames of movie clips in Supplemental Movie S2. (D) Time frames showing a single track of the
H2Bmcherry centroid (blue).
doi:10.1371/journal.pone.0005046.g002
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metabolically active but replication-defective feeders (Methods).
Monitoring the colonies permitted those arising from single hESCs
to be chosen for serial passage and expansion. Individual clonal
colonies showed reporter fluorescence during growth (Figures 3B–
F). Non-stem cells did not proliferate under these conditions
(Figure 3G). Recovery of colonies was efficient: approximately 1
colony could be isolated from approximately 13 cells deposited
(clonal efficiency of 7.7%). In a typical experiment, of 629 total
colonies obtained prior to the first passage, we monitored 24 that
were clonally derived from single cells and, of these, 12 were
frozen as before passage while 4 were propagated as distinct lines.
Figures 3H,I illustrate the uniform H2BmCherry fluorescence of
one of these colonies after the 1
st passage. The clonal PGK-
H2BmCherry hESC lines have been maintained for over 20
passages with no discernible change in intensity level or loss of
homogeneity.
Engineered clonal hESCs retain pluripotency, as demonstrated
by expression of hTERT, nanog, Rex-1 and Oct4 (Figure 4K) and
the ability to differentiate into endothelial (Figures 4D–F),
neuronal (Figures 4G–I), cardiac (see below) and endodermal
(Figure 4J) lineages. Nuclear-localized H2BmCherry fluorescence
is visible in each cell (compare Figures 4A,G to B,H). Taken
together, these protocols and lentiviral vectors provided uniformly
labeled hESCs for quantitative analyses.
T/Brachyury promoter eGFP reporter vectors
To visualize mesodermal outgrowths in hESC cultures, we used
a portion of the T/Brachyury promoter [20] that contains
elements shown to direct directs transcription in primitive streak-
stage mesendoderm, including cardiomyocyte precursors, in
transgenic mouse embryos [21]. Although absent in undifferenti-
ated hESCs, eGFP fluorescence directed from the T/brachyury
promoter vector (Figure 1A) was detectable in differentiating
mesenchymal outgrowths surrounding hESC colonies (Figures 5A–
D) permitting enrichment and isolation of positive colonies after
infection by the clonal isolation method described in Figure 4, or
by using a drug resistance procedure described in the following
section. Spatially concordant immunostaining of endogenous T/
brachyury protein demonstrated fidelity of the construct, although
cells at the border of hESC colonies typically exhibited more
endogenous T/brachyury protein than eGFP fluorescence where-
as outgrowths showed intense eGFP, perhaps reflecting lagging
kinetics of eGFP fluorescent detection relative to endogenous
protein accumulation since this 2650 to 21 region lacks
sequences that are important for high level primitive streak and
also node and notochord expression in transgenic mice [21,22].
Under EB differentiation conditions, eGFP fluorescence peaked
during days 3–5, also lagging behind endogenous T/brachyury
expression by about a day (not shown), diminishing thereafter as
expected (day 4 shown in Figure 5F). Separate studies confirmed
Wnt responsiveness of this promoter region (not shown), as noted
previously [20,23].
Drug resistance cassettes for selection of stem cells and
differentiated lineages
Drug selection cassettes were developed to enable co-selection of
stable hESC lines with integrated promoter-reporter constructs
that are not expressed in stem cells but only in differentiated
lineages. Neomycin (Neo
r) and Blasticidin (Bla
r) resistance genes
were placed under control of the Rex-1 promoter (Figure 1A).
Originally characterized in mouse embryonal carcinoma cells,
Rex-1 or expression from its minimal promoter is a marker of
pluripotency [24]. Rex-Neo
r or Rex-Bla
r cassettes enable co-
selection of stable hESC lines with integrated promoter-reporter
constructs that are not expressed in stem cells but in differentiated
lineages. The Rex-Neo
r and Rex-Bla
r selection cassettes were
incorporated into vectors with the cardiac-specific aMHC
Figure 3. Single colony expansion of hESCs. (A) Schematic
diagram of the procedure. Parental hESCs were gamma-irradiated and
used as metabolically active but replication defective feeder cells.
Lentivirally-transduced hESCs expressing a fluorescent reporter protein
were enriched by FACS and seeded at low density on to the feeders,
expanded as single colonies, and manually selected for serial passage as
indicated (Methods). (B) FACS-isolated hESCs plated onto irradiated
hESC feeder layer at low dilution after FACS. (C–F) Fluorescence
micrographs showing examples of the sorted cells at different times
after plating. Individual cells seen one day after sorting (C) grow into
small colonies as imaged at days 7, 9 and 16 (D–F) (different colonies).
(G) H2BmCherry-positive differentiated cells did not proliferate under
the expansion conditions. (H,I) Phase contrast (H) and fluorescence (I)
micrographs of clonal H2BmCherry hESCs originated from a single cell
at day 7 following passage 1.
doi:10.1371/journal.pone.0005046.g003
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(e.g. aMHC-eGFP_Rex-Neo
r and aMHC-mCherry_Rex-Bla
r;
Figure 1A). G418 or Blasticidin selection (see Methods) of infected
hESCs created non-clonal stable lines that yield fluorescently
labeled cardiomyocytes upon differentiation. Supplemental Movie
S3 shows an example of aMHC-mCherry expression throughout a
Figure 4. Pluripotency of clonal hESC reporter lines. (A–C) Outgrowths of differentiated cells from EBs derived from a clonal PGK-H2BmCherry
hESC line showed coincident H2BmCherry (A) and DAPI (B) immunostaining visible in the merged fluorescent image (C). (D–I) Clonal PGK-
H2BmCherry hESC-derived EBs developed endothelial (D–F) and neuronal (G–I) lineages. (J) Expression of endodermal genes alpha fetoprotein (AFP)
and hPDX-1 by day 20 EBs of clonal PGK-H2BmCherry hESCs (lane 2) compared to undifferentiated cells (lane 1) and isolated human pancreatic islet
tissue as positive control for hPDX-1 (lane 3) and day 20 parental H9 EBs as control for AFP (lane 3). (K) Pluripotency markers expressed by clonal PGK-
H2BmCherry hESCs (lane 2) compared to no reverse transcriptase control (lane 1) and undifferentiated parental H9 cells (lane 3).
doi:10.1371/journal.pone.0005046.g004
Figure 5. T/Brachyury eGFP hESC line. (A–D) Phase contrast (A), eGFP reporter fluorescence (B) anti-T/Brachyury immunostaining fluorescence
(C) and merged fluorescence (D) micrographs of T/Brachyury-eGFP hESCs showing overlapping expression at the edge of hESCs colonies and in
surrounding mesenchymal cell outgrowths. (E,F) Phase contrast (E) and eGFP reporter fluorescence (F) of day 4 differentiating EBs.
doi:10.1371/journal.pone.0005046.g005
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Figure S1 shows aMHC-mCherry expression coincident with
immunodetection of endogenous myosin in EBs derived from Bla
r-
selected hESCs, indicating that drug co-selection efficiently
enriched functionally transduced hESCs.
To create hESC lines for the efficient purification of
cardiomyocytes, a dual selectable marker cassette lentivirus was
constructed containing either the Rex-Neo
r or Rex-Bla
r cassettes
together with the aMHC promoter directing transcription of the
Puromycin resistance gene (aMHC-Puro
r_Rex-Neo
r and aMHC-
Puro
r_Rex-Bla
r; Figure 1A and Methods). Although bMHC is the
dominant MHC in adult human heart, we chose aMHC because
the onset of endogenous (Figure 6F) and transgene (Supplemental
Figure S1) expression is coincident with appearance of cardiomy-
ocytes as early as day 10, preceding expression of bMHC
(detectable at day 90), and persists during subsequent culture of
EBs. The Rex-Neo
r and Rex-Bla
r selection cassettes were used to
create stable aMHC-Puro
r hESC lines that have been maintained
for over 25 passages without any detectable decrease in efficacy of
either selection cassette.
The dual drug selection protocol for isolation of cardiomyocytes
from hESCs is diagrammed in Figure 6A and described in
Methods. Two days before initiation of EB formation, cultures
were treated with G418 (or Blasticidin) to remove residual MEFs
and any spontaneously differentiated hESC-derived cells
(Figures 6B,C). EBs were prepared for cardiogenic differentiation
and subsequent selection of cardiomyocytes by Puromycin, which
removed non-cardiomyocytes within 36 hours (Figures 6D,E).
Puro
r selection could be done at any point between day 12 of
culture and for up to at least 120 days, consistent with duration of
aMHC expression (Figure 6F). After Puro
r selection, cardiomyo-
cytes can be maintained as spheroidal clusters (cardiomyocyte
spheroids, CSs) attached to the substratum (Supplemental Movie
S4). CSs isolated at day 20 as were analyzed for purity by
quantifying the incidence of cardiac Troponin-I (TN-I) immuno-
stain-positive cells in histological sections. Fewer than 1% TN-I
+
Figure 6. Drug resistance selection of hESC-derived cardiomyocytes. (A) Schematic diagram of the drug selection regimen for isolation of
cardiomyocytes (see Methods). Puromycin selection is typically done for a 1.5–2 day window between day 12 and 120 days (latest attempted) after EB
formation. (B,C) Phase contrast micrographs of hESC colonies at day 22 (b) and again at day 21, after 24 hours exposure to G418 (C). (D,E) Beating
cardiomyocyte clusters at day 12 (D) and again following Puromycin treatment at day 13.5 (E). Dark color is due to opacity of the tissue. Supplemental
Movie S4 shows brightfield and fluorescence images of CSs at day 16. (F) Expression of aMHC and bMHC mRNA during differentiation in EBs (day 0–
4) and in Puro
r CSs (day 18–90), by quantitative RT-PCR (error bars represent standard deviation) showing that aMHC transcripts are evident as
cardiomyocytes emerge and persist for at least 90 days, consistent with efficacy of Puro
r selection when performed from day 12 and up to 150 days,
the latest attempted (see text). b-MHC mRNA, in contrast, was first detected at day 90. (G,H) Histological sections of a day 18 EB (G) and day 20 CS (H)
showing immunostaining of Troponin-I (red) and DAPI (blue). Cardiomyocytes were enriched in CSs, comprising 96.0%68.6, as quantified from
multiple sections of 10 independent biological replicates. (I) 3D confocal reconstruction of a 16 mm section through a CS isolated from a day 100 EB
by the Neo
r, Puro
r selection protocol from a three-vector hESC line (aMHC-Puro
r_Rex-1-Neo
r, aMHC-mCherry_Rex-Bla
r, and PGK-H2BeGFP) showing
cytoplasmic mCherry (magenta) and nuclear H2BeGFP (green). Numerous nuclei are not apparent since they are inside the reconstructed tissue.
doi:10.1371/journal.pone.0005046.g006
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+ cells were
enrichmed to 96.0%68.6 (standard deviation; n=10 independent
biological replicates) after Puro
r selection (Figure 6H and [25]),
consistent with previous reports of high purity of drug selected
cardiomyocytes [14,15]. Interestingly, free floating CSs eventually
died while those that were loosely attached remained healthy for at
least 120 days (the longest duration studied) with media exchanges
every 2 days. Residual fibroblasts commonly grew out from CSs
upon long-term culture (greater than 30 days) in serum-containing
medium but could be removed by re-treatment with Puromycin.
Puromycin treatment has been done up to 60 days following
initiation of EB differentiation without loss of efficiency.
The incorporation of Neo
r and Bla
r cassettes into different
vectors (Figure 1A) allowed drug selection for combinations of
transgenes that, like the aMHC promoter constructs, are inactive
in the stem cell state. We took advantage of this system by
engineering a single hESC line with three vectors for 1) Puro
r
selection of cardiomyocytes plus 2) visualization of cardiomyocytes
with fluorescent mCherry protein and 3) visualization of all nuclei
with eGFP (aMHC-Puro
r_Rex-1-Neo
r, aMHC-mCherry_Rex-
Bla
r, and PGK-H2BeGFP vectors). Figure 6I shows the cytoplas-
mic mCherry and nuclear H2BeGFP expression typical of Neo
r,
Puro
r-selected CSs derived from this cell line. Such cell lines will
permit the selection of pure populations of labeled cardiomyocytes
for cell mixing, tracking and in vivo engraftment studies.
Gene array profile of Neo
r, Puro
r-selected hESC-derived
cardiomyocytes
A major advantage of the CS selection protocol is that it permits
developmental, genetic and physiological studies of cardiomyo-
cytes without the potentially confounding influence of other cells
present in normally heterogeneous EBs. To demonstrate this
approach and begin to validate that the selected cardiomyocytes
retained normal function, we compared human Affymetrix exon
array data from the day 40 CSs to undifferentiated hESCs, which
had been treated with G418 to ensure that they were free of
differentiated cells. 3030 genes were up- or down-regulated in the
day 40 CSs relative to the hESCs. Further comparison of these day
40 CS profiles to adult heart arrays identified 6 out of 9 gene
clusters with analogous expression profiles (Figure 7B). A subset of
well-characterized cardiac and embryonic stem cell pluripotency
genes are displayed in a non-clustered heatmap along with
previously described neural differentiation datasets [26] and a
panel of adult tissue samples (http://www.affymetrix.com/
support/technical/sample_data/exon_array_data.affx) (Figure 7A).
Adult heart and day 40-CS showed concordant up-regulation of
all cardiac developmental and adult heart markers examined.
To determine the common and distinct pathways to which these
genes aligned, we performed pathway over-representation analysis
with the tool GO-Elite (Figures 7C–E). Cellular cardiac differenti-
ationpathways,aswellasmorecomplexinvivotissuedevelopmental
pathways, were enriched among both CS and adult heart
upregulated genes (Figure 7C). The adult heart had a greater
proportion of up-regulated genes per corresponding gene ontology
(GO) term, but with equivalent z-scores and p-values, as expected
since adult heart had a larger number of upregulated genes. While
the large majority of pathways were regulated in common, pathways
reflecting in vivo tissue processes including cellular metabolism,
immune response, taxis and fluid transport were enriched in adult
heart over day 40 CS samples (Figure 7D), as expected since they
correspond to whole heart and endothelial cell function missing in
the CSs. For pathways in which CS genes were up-regulated and
heart genes were not, neural, stem cell and early developmental
processes were the most enriched (Figure 7E). Similarity of hESC-
derived cardiomyocytes to adult cardiomyocytes was also described
by Synnergren et al. [27], who analyzed manually dissected beating
areas that are enriched for cardiomyocytes but also would be
expected toinclude alargepercentageofnon-cardiomyocytes.Thus,
this is the first analysis of pure hESC-derived cardiomyocyte gene
expression data and the gene data can be downloaded (Supplemen-
tal Data).
Neo
r, Puro
r-selected hESC-derived cardiomyocytes
exhibit action potentials consistent with early embryonic
fetal cardiomyocytes
We next verified that the drug selection protocol does not
adversely affect the electrophysiological phenotypes of the
cardiomyocytes. Electrophysiological phenotypes of cardiomyo-
cytes in the Neo
r, Puro
r-selected CSs at day 20 of differentiation (8
days after Puromycin treatment of day 12 EBs) were obtained by
intra-cellular recording techniques (see Methods). As shown in
Figure 8A, the majority of selected cardiomyocytes displayed
action potentials (APs) with relatively depolarized maximal
diastolic potentials (MDPs, .245 mV) and slow maximal rate
of AP depolarization (Vmax, ,5 V/s). Figure 8B shows that 10–
20% of cardiomyocytes, however, possess MDP,245 mV and
faster Vmax (.5 V/s). The electrophysiological parameters of
these APs are summarized in Figure 8C. Overall, the electro-
physiological properties of the CS cardiomyocytes were similar to
those of human fetal cardiomyocytes [28].
Force generation of isolated hESC-derived
cardiomyocytes
As a third validation of the dual drug selection protocol,
contractile forces in individual, selected cardiomyocytes were
measured using a method of dynamic traction force microscopy as
described [see Methods and 29]. CSs were dispersed and
individual cardiomyocytes plated onto polyacrylamide gels
(Figure 9A) with an elastic modulus of 4 kPa and surfaces
functionalized with chemically cross-linked, gelatin (Methods).
Individual cells were paced (0.5 Hz with 0.8 ms pulses at 50 V)
and images of fluorescent bead displacements caused by the
cardiomyocytes at the gel surface were acquired every 15 ms
(Supplemental Movie S5). Bead displacements were tracked using
a cross-correlation-based optical flow algorithm (Methods) and
mapped in order to determine localized stresses, or traction forces.
Figure 9B shows a-actinin immunostaining revealing the charac-
teristic striations of the plated cardiomyocytes and Figure 9C
shows an example of bead displacements (red arrows) correlated
with traction forces (blue arrows). Average traction force
magnitude in hESC-derived cardiomyocytes was 220670 Pa
and was similar to that of neonatal rat ventricular cardiomyocytes
(NRVCs) of 340670 Pa. The traction forces were integrated over
the projected cell area in order to calculate axial and total force. A
sample plot of axial force as a function of time is shown in
Figure 9D. Selected hESC-derived cardiomyocytes (N=11)
contracted with an average axial force of 139629 nN and a total
force of 144633 nN. These values did not change appreciably
with time in culture after isolation (up to 90 days, not shown). For
comparison, NRVCs contracted with an average axial force of
202647 nN and a total force of 222654 nN on the same gels
using the same protocol (Supplemental Figure S2C). Cell spread
area between these cells is similar and the differences in total force
are primarily due to differences in generated traction. NRVCs had
a higher aspect ratio, calculated as the length of the long axis
divided by the length of the short axis, than the hESC-derived
myocytes, of 4.2+/20.2 versus 3.0+20.3. However, the ratio of
hESC Cardiomyogenesis
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PLoS ONE | www.plosone.org 8 April 2009 | Volume 4 | Issue 4 | e5046the axial to total force was 0.93+/20.02 in the hESC-derived cells
and 0.93+/20.02 in NRVCs, indicating that variations in
morphological alignment did not impact the polarization of force
generation. Average velocity of contractions was measured as
6.962.1 mm/s for hESC-derived cardiomyocytes and
9.761.5 mm/s for NRVCs. Thus, drug-selected hESC-derived
cardiomyocytes generated contractile force comparable to that of
NRVCs providing further evidence of normal behavior after
selection from the engineered hESCs.
Discussion
We describe single cell cloning and drug selection procedures
methods and a suite of lentiviral vectors to engineer hESC lines
for visualization, tracking and purification of pluripotent
stem cells and their differentiated cardiomyocyte derivatives.
These methods overcome variegation and downregulation of
fluorescent reporters and other markers observed without
enrichment (Figure 1 and reported previously [11,13]). The
FACS and cloning protocols yielded homogeneous levels of
fluorescent reporter protein expression sufficient for automated
tracking and quantitative analyses, such as biosensors of DNA
content (Figure 2B), and the protocols and vectors could be
broadly applied to biosensors of subcellular structures or signal
transduction pathways (such RhoA fluorescence resonance
energy transfer biosensors [30]) as well as improving the
identification of hESC derivatives after engraftment in animal
models of disease or regeneration.
Although the experiments shown were performed using H9 cells
(WiCell WA09), similar outcomes were obtained with the PGK-
H2B fluorescent protein vectors, Rex- and aMHC-driven
fluorescent and selectable markers using HUES13 (Harvard) and
human induced pluripotent stem cells (hIPSCs) derived in our
laboratory.
Figure 7. Comparison of day 40 cardiomyocyte spheroids and adult heart gene expression profiles. (A) Human Affymetrix exon
microarray data for Neo
r undifferentiated hESCs and Puro
r CSs (isolated as in Figure 6a and analyzed at day 40 of culture) were combined with a
previously described neural differentiation dataset (Cythera, HUES6 and fetal hCNS stem cells) in addition to adult tissue samples using the RMA
algorithm (ExpressionConsole 1.0). A non-clustered heatmap of well-characterized cardiac and embryonic stem cell pluripotency genes are displayed
for all combined differentiation and adult tissues, relative to their respective undifferentiated hESC controls (adult tissue compared to Neo
r hESCs
from this study). (B) Individual array fold changes for day 40 CS and adult heart, relative to Neo
r undifferentiated hESCs were clustered using the
HOPACH algorithm (Bioconductor), for 3030 genes up or down-regulated in the day 40 CS comparison. Genes clustered into one of nine top-level
clusters (indicated), where red and green indicate gene up- and down-regulation, respectively, relative to undifferentiated hESCs. (C–E) Pathway
over-representation analysis with the tool GO-Elite of the 1466 and 2502 upregulated genes in day 40 CS and adult heart samples, respectively,
relative to undifferentiated hESCs as a function of the percentage of the genes changed per GO term. Cellular cardiac differentiation and complex
tissue developmental pathways were enriched in both samples (C). Genes disproportionately enriched in adult heart aligned with in vivo tissue
processes typical of whole heart and endothelial function (D). Genes disproportionately enriched in day 40 CS samples (E) included stem cell and early
developmental processes.
doi:10.1371/journal.pone.0005046.g007
Figure 8. Electrophysiological properties of Neo
r, Puro
r-selected, hESC-derived cardiomyocyte spheroids at day 20 of
differentiation. (A) The dominant electrophysiological phenotypes of action potentials (APs) of cardiomyocytes recorded from day 20 CSs. (B)
Some cardiomyocytes displayed more hyperpolarized MDP and faster Vmax. Left panels (a and b) show expanded time scale and right panels show 3
APs. (C) The summary table of electrophysiological parameters of action potentials.
doi:10.1371/journal.pone.0005046.g008
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selection of pluripotent stem cells with G418 or Blasticidin and
cardiomyocytes with Puromycin. The two-stage selection proce-
dure (Figure 6) first eliminated feeder and spontaneously
differentiating cells, which in our hands compromise cardiomyo-
cyte differentiation in EBs (not shown). Puromycin selection
yielded greater than 96% pure cardiomyocytes at or after day 12.
We exploited the purification procedure to profile hESC-derived
cardiomyocytes gene expression with the finding that their profile
strongly resembled that of the adult human heart. Additionally,
the selected cardiomyocytes exhibited action potentials that
resemble human fetal cardiomyocytes. Additional electrophysio-
logical analysis of the early hESC-derived cardiomyocytes
(Puromycin treatment at up to 20 days) reveals that the typically
immature calcium handling apparatus and the proportion of cells
with immature (versus ventricular-like) action potentials do not
change with continued culture; however, we found that culture
within the context of the EB promotes maturation of these
electrophysiological parameters [25], implicating critical signals
from non-cardiomyocytes.
The hESC-derived cardiomyocytes generated contractile forces
characteristic of fetal cardiomyocytes, illustrating the utility of the
approach for developmental and physiological studies and
providing further validation that the cardiomyocytes produced
by drug selection from the engineered hESCs were normal by
multiple physiological criteria. It should be noted that these
measurements were performed on gels with mechanical properties
(4 kPa) much softer than the adult myocardium (10–20 kPa) in
order to improve the resolution of the dynamic traction force
microscopy, which increases as the shortening length increases,
Figure 9. Force generation of individual day 50 Neo
r, Puro
r-selected cardiomyocytes. CSs were isolated at day 12–13.5 and cultured until
day 48 when they were dispersed and deposited onto gelatin-functionalized surfaces of polyacrylamide cast with fluorescent beads and analyzed for
force generation at day 50. (A) Diagram of the apparatus containing the polyacrylamide. Platinum electrodes were used to electrically pace the
cardiomyocytes at 0.5 Hz with 0.8 ms pulses of 50 volts. Inset shows micrograph of fluorescent beads. Scale bar represents 10 mm. (B) a-actinin
immunostaining of hESC-derived cardiomyocytes on the functionalized surface shows characteristic striations. Scale bar represents 10 mm. (C) Bead
displacements near individual cardiomyocytes (Supplemental Figures S2A,B and Movie S4) were tracked using a cross-correlation-based optical flow
algorithm in order to map deformations (red arrows) or stresses (blue arrows) across the face of the gel corresponding to individual cardiomyocytes
[29]. Red arrows mark local bead displacement length is as per red scale bar (1 mm), which is expanded 206relative to that of the image (white bar
represents 10 mm) to permit visualization. Blue arrows indicate force magnitude as per blue scale bar [1 nN/mm2 (equivalent to 1 kPa)]. (D) Sample
plot of total, transverse and longitudinal force versus time for a cardiomyocyte as in (C).
doi:10.1371/journal.pone.0005046.g009
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has less collagen content than adult heart. Reduced stiffness is
expected to result in lower force because increased shortening
decreases force generation. It is to be expected that more mature
cells would generate much greater contractile force. For
comparison, we found that adult cardiomyocytes from rabbits at
slack length contraction, with sarcomere lengths near 1.8 mm,
generate forces ranging from 500 nN to 2700 nN depending on
the stimulation frequency[31]. Active stresses in these cells are
again an order of magnitude greater than the hESC-derived
cardiomyocytes, ranging from 3000 to 5000 Pa. In addition, the
two-dimensional geometry of this cell culture could further
decrease the force generated compared to a more physiological
three-dimensional environment.
Cell tracking using the PGK-H2BmCherry- and PGK-
H2BeGFP-containing vectors will enable stem cells and their
differentiated derivatives, regardless of lineage, to be followed in
cell mixing and in vivo engraftment studies. The heritable and
ubiquitously expressed reporters can be used to quantify
regeneration of functional cardiomyocytes as well as persistence
of non-cardiomyocyte derivatives of the graft, such as fibroblasts or
de-differentiated cells as well as residual stem cells with
tumorigenic potential. Moreover, application of the H2B fluores-
cent fusion proteins as sensors of DNA content in a 2-D tracking
study (Figure 2B) showed feasibility of using the reporter to
evaluate parameters such as cell migration and differentiation that
also should be applicable to studies of tissue architecture in 3-D
cultures, as recently reported [32].
In conclusion, we have described a toolbox of lentiviral vectors
and protocols for cell line creation and isolation of pure
cardiomyocytes that provide the means for a wide range of studies
aimed at improving cardiomyocyte differentiation from stem cells
and their functional incorporation into damaged myocardium.
Methods
hESCs and culture conditions
Low passage hESCs (H9, WiCell) were used. Similar results
were obtained using HUES13 (Harvard) and hIPSCs derived in
our laboratory. Undifferentiated hESCs were cultured as de-
scribed [33] with slight modification. Briefly, cells were cultured in
Knockout Dulbecco’s modified Eagle’s medium (KODMEM,
Invitrogen, 10829-018) supplemented with 1 mM L-glutamine
with 20% Knockout Serum Replacement medium (KOSR,
Invitrogen), 1 mM sodium pyruvate, 0.1 mM nonessential amino
acids (NEAA, Invitrogen), 50 U/ml penicillin, 50 mg/ml strepto-
mycin (Invitrogen), 0.1 mM beta-mercaptoethanol (Invitrogen)
and 8 ng/ml basic fibroblast growth factor (bFGF, Sigma
catalogue F0291-25UG). hESCs were grown on Matrigel (growth
factor-reduced, BD Bioscience)-coated 6-well plates (Corning, Inc.
catalogue 3506) on a feeder layer of primary MEFs from E13.5
CD-1 mice isolated as described [33]. Passage 3 to 4 MEFs were
gamma-irradiated with 3,000 rads (30 Grays) and plated at 10
4
cells per cm
2. All hESC lines were passaged following enzymatic
digestion with either collagenase IV (Invitrogen, 17104-019)
approximately every 7 days or Accutase (Chemicon) approxi-
mately every 10 days [34], depending on cell condition and
confluency. For collagenase treatment, cells were exposed to
1 mg/ml in KODMEM, sterile filtered, at room temperature.
Once the edge of colonies were about to lift from the plate, the
cells were rinsed twice with DPBS (Ca
2+- and Mg
2+-free), culture
medium was added and cells were mechanically dispersed into
100–500-cell clusters by trituration using a 5 ml pipette and re-
plated. For Accutase treatment, cells were washed twice with
DPBS and then subsequently washed with a small amount of
Accutase (16 concentration, Innovative Cell Technologies) and
then exposed to Accutase at room temperature. After a few
minutes, when MEFs and hESC-derived fibroblasts began to lift
from the plate, accutase was removed and hESCs were washed
twice with DPBS (Ca
2+- and Mg
2+-free) to remove MEFs and
hESC-derived fibroblasts. A third of the volume of culture
medium normally used was added and the stem cells were
mechanically dispersed into 10–50-cell clusters by trituration as
above. Each passage was a 1:3 split ratio for collagenase IV-treated
cells and 1:4 to 1:6 ratio for accutase-treated cells. Cells were
routinely tested for mycoplasma (MycoAlert; Cambrex, Walkers-
ville, MD).
Lentivirus vector design, preparation and hESC infection
The SIN18.WPRE lentiviral vector [35] was modified by
insertion of the promoter regions and the drug selectable or
fluorescent proteins (Figure 1A; see Supplemental Figures S3, S4,
S5, S6, S7, S8, S9, S10 for individual schematics). Vectors and
schematics are available at [insert web site of public source once
available]. The lineage-specific vectors included gene promoters for
T/Brachyury [20] [2645 bp to 21 bp relative to ATG (includes
152 bp of 59UTR)] and aMHC [36] [25446 bp to 24 bp relative
to ATG (includes non-coding exons 1,2 and UTR of exon 3)] with
the stem cell selective Rex-1 (also known as zinc finger protein 42)
promoter [24] (21062 bp to 2357 bp relative to ATG) to direct
the selectable markers. The ubiquitously expressed human PGK
promoter (2528 bp to 213 bp relative to ATG) directed
expression of the H2B-fluorescent fusion proteins.
SIN18.WPRE-based lentivirus production in HEK 293T cells
was as previously described [35,37], followed by purification and
concentration by ultra-centrifugation. Briefly, three plasmids
(transfer vector with expression construct, the packaging plasmid
pCMVDR8.74, and the VSV-G envelope protein expression
plasmid pMD.G) were mixed in a ratio of 3:2:1 and 293T cells
were transiently transfected using calcium phosphate method and
viral supernatant from the transfected plate was collected every
24 hours in serum-free Ultraculture medium (Bio-Whitttaker
#12-725F) with 1 mM L-glutamine, 50 U/ml penicillin, 50 mg/
ml streptomycin up to 4 days after the transfection. The pooled
viral supernatant was concentrated by ultracentrifugation at
21,000 rpm for 2 hours at 4uC, passed through 0.22 or 0.4 mm
filters, and aliquots were used to transfect the hESCs.
For infection, confluent hESCs, in one well of a 6-well plate,
were lightly dissociated with 1 mg/ml collagenase 7 days after the
last passage and rinsed twice with DPBS. The small cell clumps of
approximately 100 to 200 cells were resuspended in 1 ml of
culture medium and collected upon settling in 15 ml conical tube
for 5 min at room temperature. 500 ml of the supernatant was
exchanged with fresh 400 ml fresh media and 8 mg of polybrene.
Finally 100 ml of the concentrated virus supernatant was added
and mixed with the cells and incubated at 37uC for 4 to 6 hrs. The
cell/virus suspension was mixed occasionally during the incuba-
tion and then plated on to one or two wells of the Matrigel-coated
wells with MEF cells and cultured overnight. 1 ml of the culture
media was added to the cells on the next day and the virus
particles were washed out 36 hours after the infection by medium
change.
G418 and Blasticidin selection of drug resistant hESC
lines
Four days after virus infection, hESCs were treated with either
G418 (400 mg/ml) or Blasticidin (5 mg/ml) for 36 hours, rinsed
twice with DPBS to remove drugs, and cultured for two to three
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cells were then treated with the same drug a second time and
allowed to recover, as before, until colonies attained sufficient size
and cell density for passage.
FACS purification and cloning of hESCs
Figure 3A diagrams the FACS isolation and clonal expansion
procedure. Plates of irradiated feeder hESCs were set up six days
prior to FACS of the cells intended for clonal expansion by plating
parental hESCs onto Matrigel-coated 6-well plates under regular
maintenance culture conditions with MEFs as above. On the
morning of the day when needed as feeders, these plates were
gamma-irradiated with 3,000 rads (30 Grays), rinsed twice with
DPBS, and medium exchanged with fresh H9 maintenance
medium.
To generate a single-cell suspension for FACS, hESCs were
dispersed with Accutase (16) for 10 to 15 minutes at room
temperature and cells were collected by centrifugation at 200 rpm
for 5 minutes and the medium was exchanged to regular culturing
medium and kept at room temperature until use. The dissociated
hESCs (adjusted to 10
6 cells/ml) were stained with SytoxGreen
(Invitrogen) or 7-AAD (7-amino-actinomycin D, BD Bioscience)
prior to sorting on a FACSVantage
TM. Cell debris, cell clumps,
dead cells and MEFs were gated out before sorting. Dissociated
hESCs were sorted in pre-warmed 100% KOSR and then diluted
with pre-warmed culture media and seeded on top of the
irradiated hESC feeder plates at 10,000 to 20,000 cells/well final
concentration on Matrigel-coated 6-well dishes (Corning, Inc.
catalogue 3506) with 20% and 40% of KOSR, respectively. Fresh
medium was added occasionally but not exchanged until day 7
post-FACS and then exchanged every day thereafter. Single
colonies were passaged onto irradiated MEFs in a well of a 24-well
dish on day 18 after which they were expanded onto successively
larger wells with each passage (Figure 3) with clonal cells reaching
confluence in 6-well format approximately 50 days post-FACS.
hESC differentiation
Figure 6A schematically illustrates the protocol for obtaining
Neo
r, Puro
r (or Bla
r, Puro
r) cardiomyocytes. Undifferentiated
hESC colonies were plated onto Matrigel-coated 6-well dishes
(Corning Inc. Cat No. 3506) that had been seeded with 42,000
MEF cells/well and cultured until use. Prior to initiation of EB
formation, the cells were treated with G418 (400 mg/ml; 16)o r
Blasticidin (5 mg/ml; 16) for 36 hours to remove residual MEFs
and hESC-derived fibroblasts. Because the MEFs were removed,
it was necessary to exchange media at this point (day 22) and
again the next day (day 21) with 50% MEF-conditioned media
and 50% hESC culturing media. Differentiation was initiated by
EB formation on day 0 by treatment with 1 mg/ml collagena-
seIV followed by two rinses with DPBS to remove any residual
MEFs. The collagenase IV-treated colonies were dispersed by
mechanical pipette trituration into cell aggregates of 500 to 800
cells. Aggregates were collected into 15 ml plastic tubes in
cardiogenic medium [KODMEM supplemented with 20% fetal
bovine serium (FBS; Hyclone), 1 mM L-glutamine, 1 mM
sodium pyruvate, 0.1 mM NEAA, 50 U/ml penicillin, 50 mg/
ml streptomycin, and 0.1 mM beta-mercaptoethanol] and
allowed to settle for 5 minutes at room temperature. The
supernatant containing single cells and cell debris was carefully
removed and the pellet rinsed twice with medium before being
re-plated on low attachment plates (Corning, Inc. Costar 3171).
The medium was exchanged on day 2 and on every second day
thereafter. After 6 days in suspension, EBs were transferred onto
0.1% gelatin-coated bacterial culture dishes where they attached.
Cardiomyocytes generally started to appear on day 9. Cardio-
myocytes were purified from aMHC-Puro
r hESCs by treatment
with 1.8 mg/ml Puromycin for 36 hours at day 12 to14 and
washed twice with DPBS.
For neuronal differentiation, EBs were prepared as above but
with aggregates of approximately 50 to 100 cells in neurogenic
medium [DMEM/F12 medium (Invitrogen) supplemented with
0.1 mM NEAA, 16 N-2 supplement (Invitrogen, catalogue
17502), 16 B-27 supplement (Invitrogen, catalogue 17504),
25 mg/ml bFGF (Chemicon)] in place of cardiogenic EB medium.
For endodermal differentiation, EBs were prepared as above but
with aggregates of approximately 100 to 200 cells in endodermal
EB medium [DMEM/F12 medium supplemented with 20% FBS
(Hyclone), 0.1 mM NEAA, 0.1 mM beta-mercaptoethanol].
RT-PCR
Total RNA was extracted using acid-guanidium-phenol-chlo-
roform and cDNA was synthesized using the QuantiTect Reverse
Transcription kit (Qiagen) and amplified products measured by
Syber Green incorporation on the LightCycler (Roche). The
following primers were used: hAMHC_U5619, GAAGGGCAT-
GAGGAAGAGTGA; hAMHC_L5901, GGTTATTCCTCG-
TCGTGCATC; hBMHC_U5242, AGAACACCAGCCTCAT-
CAACC; hBMHC_L5639, CTGTCCTCCTCCGTCTGGTAG;
hbACTIN_U, GAGCATCCCCCAAAGTTCACA; hbAC-
TIN_L, GCAATGCTATCACCTCCCCTG; hPDX-1_U,
CCGCAGGAACCACGATGAGA; hPDX-1_L, GCCACAAA-
CAACGCCAATCC; hAFP_U, GTCGTTTTGTCTTCTCT-
TCC; hAFP_L, GCCACAAATAACAGAGGAAC. Oct-4, Na-
nog, Rex-1 and hTERT primers were as in [38].
Immunohistochemistry
Cells were washed with warm PBS, fixed with ice-cold MeOH
at 220uC for 7 minutes and then incubated with DPBS for
10 minutes at room temperature. Cells were blocked with
1%BSA/PBS for 1 hour and then incubated in primary antibodies
for 1 hour at room temperature. After three 10-minute washes
with PBS, the secondary antibody solution was incubated for a
period ranging from 40 minutes to overnight at 4uC and then
washed three times with PBS prior to mounting with SlowFade
mounting medium with DAPI (Invitrogen). Histological sections
were sectioned in OCT at 8 mm and stained as above to quantify
percentage of cardiomyocytes in CSs. Cardiac Troponin-I
(Alomone Labs), MAP2 (Chemicon), CD31 (eBiosciences), and
appropriate AlexaFluor488 (Invitrogen), Cy3 or Cy5 (Jackson
ImmunoResearch) secondary antibodies were used for immuno-
staining.
Microscopy and DNA content determination
For cell tracking and DNA content determination, differentiat-
ing hESCs were plated in 2 ml of appropriate differentiation
medium for two days prior to recording onto 0.17-mm thick Delta
T glass-bottom culture dishes (Biotechs, Butler, PA) that had been
coated with 0.1% gelatin for 1 hr at room temperature. The dishes
were then sealed with parafilm and mounted on the stage of an
inverted Nikon microscope equipped with electronically controlled
shutters, filter wheels, and a 14-bit cooled CCD camera (Orca II,
Hamamatsu Corporation) controlled by MetaMorph software
(Molecular Devices, USA). Time-lapse images were acquired for
up to several days at a time. H2BmCherry, H2BeGFP and DAPI
integrated fluorescence intensity was calculated and cell tracks
were created using MetaMorph and a modified version of Particle
Tracking Plugin for ImageJ [17].
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Total RNA was extracted as described [26] for biological
triplicates of Rex-Neo
r hESCs and Rex-Neo
r, aMHC-Puro
r day
40 CSs for microarray sample preparation. Total RNA with a
concentration of ,1 mg, was treated with the RiboMinus human
Transcriptome Isolation kit (Invitrogen) and used as input for the
GeneChipH WT cDNA Synthesis and WT Terminal Labeling kits
(Affymetrix), according to manufacturers instructions by the
Gladstone Institutes Genomics Core. The resulting fragmented
and labeled cDNA were hybridized to individual Human Exon 1.0
ST GeneChip arrays and scanned according to manufacturers’
instructions. Affymetrix CEL files from these samples were
combined with CEL files for the Cythera neuronal precursor
differentiation datasets (Cy-ESCs and Cy-NPs), HUES6 cell line
experiment (HUES6-ESCs and HUES6-NPs) and fetal human
CNS stem cells (hCNS-SCs), provided by the Gage laboratory
(http://www.snl.salk.edu/ ˜geneyeo/stuff/papers/supplementary/
ES-NP) and 33 CEL files for 11 different adult human tissues
obtained from the Affymetrix website (http://www.affymetrix.
com/support/technical/sample_data/exon_array_data.affx).
RMA [39] expression values and detection p-values were
obtained for all probesets using the Affymetrix program,
ExpressionConsole (http://www.affymetrix.com/products/
software/specific/expression_console_software.affx). To calculate
gene expression values from the exon array data, we developed a
program in python called ExpressionBuilder. Expression builder
aligns probeset genomic coordinates to Ensembl genes and exons
along with probeset to transcript associations from the Affymetrix
probeset annotation file (HuEx-1_0-st-v2.na23.hg18.probeset.csv)
to identify probesets that are most common (constitutive) to all
transcriptsforanEnsembl gene.Constitutivegeneexpression values
weredetermined fromthemeanoftheprobesetlog2intensityvalues
of all constitutive probesets. If no constitutive probesets are present,
gene expression is calculatedby the mean of all gene linked probeset
intensities. To determine differential expression, fold changes and
T-test p-values were calculated from the log2 expression data for
differentiated cell sample arrays compared to the appropriate
undifferentiated hESC baseline (Rex-Neo
r H9, Cythera or HUES6
lines).
Differentially expressed genes (absolute fold.2 and p,0.05) for
day 40 CS samples compared to Rex-Neo
r hESCs were clustered
along with differentially expressed genes (same criteria) in adult
heart compared to Rex-Neo
r hESCs (no filtering) using the
clustering method HOPACH (hierarchical ordered partitioning
and collapsing hybrid) in R [40]. The resulting cluster data was
visualized in the program TreeView [41]. Gene Ontololgy over-
representation analysis and tree filtering were performed using the
freely available software GO-Elite (http://www.genmapp.org/
go_elite/go_elite.html).
Downloadable Gene Expression Dataset
The hESC and tissue derived gene expression data can be
downloaded at http://conklinwolf.ucsf.edu/informatics/Mercola/
DATASET-all-tissues_all-hESCs_all_diff-rma-exon.zip. For 3472
Ensembl gene identifiers, mean fold change and ttest p-values are
provided along with log2 expression values for all in vitro and in
vivo cell/tissue derived exon arrays. This data is accompanied by
gene annotations including probesets for which the values are
derived, associated Affymetrix transcript clusters and HOPACH
cluster data (used in Figure 7).
Intracellular recordings with sharp electrode technique
CSs were plated on coverslips coated with 0.1% gelatin and the
coverslips were mounted in a chamber on the stage of an inverted
microscope (Olympus IX71) and superfused with extracellular
DMEM containing 1.8 mM Ca
2+. All experiments were conduct-
ed at 37uC and the extracellular DMEM was continuously pre-
oxygenated with 95% O2/5% CO2. Sharp glass microelectrodes
are fabricated with resistances of 50–200 MV when filled with
3 M KCl. The spontaneously beating CSs were then impaled with
the microelectrodes and electrode capacitance was nullified. The
intracellular recordings of APs were obtained using an AxoPatch
200B amplifier in current clamp mode and pCLAMP-10 software
(Molecular Devices). Data were sampled at 10 kHz and low pass
filtered at 5 kHz. The following parameters of APs with more than
10 seconds of stable baselines were measured: AP amplitude
(APA), maximum diastolic potential (MDP), maximal upstroke
velocity (Vmax), AP duration at 90% of the repolarization
(APD90), and the cycle-length between two spontaneous APs
(RR). The APD90 is corrected by heart rates with Bazett formula
(APD/square root of RR).
Single cell force measurements
Contractile forces in individual cells were measured using a
method of dynamic traction force microscopy [29]. Briefly,
polyacrylamide gels with an elastic modulus of 4 kPa were
polymerized using 4% acrylamide (BioRad), 0.2% bisacrylamide
(BioRad), 5% fluorescent beads (Molecular Probes), 0.1%
ammonium persulfate (Sigma) and 0.5% N,N,N9,N9-Tetra-
methylethylenediamine (TEMED, Biorad). These gels were
bound to cover slips coated with 3-aminopropyltrimethoxysilane
(Sigma) and 0.5% glutaraldehyde (Sigma). Gels were coated with
0.5 mg/ml of rat tail type I collagen (Sigma) bound through the
heterobifunctional crosslinker N-Sulfosuccinimidyl-6-[49-azido-
29-nitrophenylamino] hexanoate (sulfo-SANPAH, Pierce). Con-
tractile CSs were manually transferred to 0.1% gelatin-coated
plates for 24 hours and then dispersed into single cells by
incubating in 0.25% Trypsin-EDTA (Gibco) for 30 minutes at
37uC. Individual cardiomyocytes were resuspended in serum-
containing media and plated onto collagen-coated polyacryl-
amide gels at a density of 20,500 cells per gel and allowed to
attach to substrates overnight.
Individual cells were stimulated at 0.5 Hz with 0.8 ms pulses of
50 V using a platinum electrode. Images of fluorescent beads at
the gel surface were taken every 15 ms (Supplemental Movie S5).
Bead displacements were tracked using a cross-correlation-based
optical flow algorithm in order to map deformations across the
face of the gel [42]. These displacements, along with the gel elastic
modulus and Poisson Ratio were used to calculate a map of shear
stress on the gel surface based on the Boussinesq solution of
deformation in an infinite elastic half space [43]. These stresses, or
traction forces, were integrated over the projected cell area to
calculate force, which is then graphed versus time. Force vectors
were projected along the major axis of contraction in order to
calculate the reported axial force.
Supporting Information
Figure S1 Co-incident fluorescent reporter and myosin expres-
sion in EBs derived from engineered hESCs. Examples of
differentiating EBs from aMHC-Puror_Rex-Neor, aMHC-
mCherry_Rex-Blar, PGK-H2BeGFP hESC line created by
G418 and Blasticidin selection. EBs were plated onto gelatin at
day 6 of differentiation and processed for immunochemistry at day
10. Micrographs of two EBs imaged at 106(E–H) and 206(A–D)
showing DAPI (A,E), mCherry (B,F) and MF20 immunostaining
(C,G) and merged (D,H) fluorescence. mCherry and MF20
immunostaining fluorescence were coincident in Blasticidin-
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removing non-functionally transduced cells.
Found at: doi:10.1371/journal.pone.0005046.s001 (9.04 MB TIF)
Figure S2 Bead displacement and force generation by day 50
hESC-derived cardiomycytes. Individual hESC-derived cardio-
myocytes were deposited onto gelatin functionalized surfaces of
polyacrylamide gels incorporating fluorescent beads (see Methods).
(A,B) Fluorescent micrographs of bead surface beneath a
cardiomyocyte when relaxed (A) and contracted (B). Bead
displacements were plotted as deformations or stresses, with
displacement vectors as red arrows. Panels are individual frames
from the stack shown as Supplemental Movie S5. White scale bars
(10 mm) are for the image. Red scale bars (1 mm) represent the
scale of the displacement arrows that are expanded 20-fold for
visualization. (C) Example of a stress map across the face of the gel
during contraction of the hESC-derived cardiomyocyte causing
the displacement in (B). The scale bar represents 10 um and scale
arrow represents 0.1 nN/mm2. (D) Sample plot of total force over
time for hESC-derived cardiomyocyte (dashed) and control
neonatal rat ventricular cardiomyocyte (solid) showing similar
force generation.
Found at: doi:10.1371/journal.pone.0005046.s002 (2.19 MB TIF)
Figure S3 Schematic of T/Brachyury-eGFP.
Found at: doi:10.1371/journal.pone.0005046.s003 (0.42 MB TIF)
Figure S4 Schematic of T/Brachyury-eGFP_Rex-Neo.
Found at: doi:10.1371/journal.pone.0005046.s004 (0.45 MB TIF)
Figure S5 Schematic of aMHC-mCherry_Rex-Blar.
Found at: doi:10.1371/journal.pone.0005046.s005 (0.28 MB TIF)
Figure S6 Schematic of aMHC-eGFP_Rex-Neor.
Found at: doi:10.1371/journal.pone.0005046.s006 (0.45 MB TIF)
Figure S7 Schematic of aMHC-Puror_Rex-Neor.
Found at: doi:10.1371/journal.pone.0005046.s007 (0.41 MB TIF)
Figure S8 Schematic of aMHC-Puror_Rex-Blar.
Found at: doi:10.1371/journal.pone.0005046.s008 (0.41 MB TIF)
Figure S9 Schematic of PGK-H2BmCherry.
Found at: doi:10.1371/journal.pone.0005046.s009 (0.55 MB TIF)
Figure S10 Schematic of PGK-H2BeGFP.
Found at: doi:10.1371/journal.pone.0005046.s010 (0.50 MB TIF)
Movie S1 Example of uniform PGK-H2BeGFP fluorescence in
nuclei of cardiomyocytes derived from a FACS isolated hESC line.
Automaticity is evident by spontaneous contractions. Inset shows
phase contrast brightfield image.
Found at: doi:10.1371/journal.pone.0005046.s011 (1.15 MB
MOV)
Movie S2 Example of cell tracking using PGK-H2BmCherry
hESCs. Time-lapse image stacks of PGK-H2BmCherry ESCs over
20 hours were acquired with a 106 objective (NA 0.5) at
10 minute intervals using MetaMorph. Centroids of H2BmCherry
fluorescence were tracked automatically using a modified version
of the Particle Tracking Plugin [17] for ImageJ (Methods). The 4
concatenated clips correspond to single tracks within the yellow
boxes in Figure 2C.
Found at: doi:10.1371/journal.pone.0005046.s012 (1.52 MB
MOV)
Movie S3 Example of cardiomyocytes labeled with aMHC-
mCherry. The hESC line was engineered with aMHC-Puror_-
Rex-Neor and aMHC-mCherry_Rex-Blar vectors (Figure 1A) by
G418 and Blasticidin selection (Methods). Phase contrast and
fluorescence images show mCherry+ cardiomyocytes within the
EB plated on gelatin-coated cell culture plastic without Puromycin
treatment.
Found at: doi:10.1371/journal.pone.0005046.s013 (2.45 MB
MOV)
Movie S4 Example of cardiomyocyte spheroid uniformly labeled
with aMHC-eGFP Example of a dual drug selected CS from a
hESC line engineered with aMHC-Puror_Rex-Blar and aMHC-
eGFP_Rex-Neor vectors (Methods). Phase contrast and eGFP
fluorescence image stacks were acquired 3 days following
Puromycin drug selection (corresponding to day 16 after EB
formation, see Methods).
Found at: doi:10.1371/journal.pone.0005046.s014 (1.63 MB
MOV)
Movie S5 Bead displacements used to calculate axial force of
individual cardiomyocytes. Bead displacements in gels were
tracked using a cross-correlation-based optical flow algorithm in
order to map deformations (Supplemental Figure S1B) and stresses
(Supplemental Figure S1C) across the face of the gel correspond-
ing to individual cardiomyocytes [42].
Found at: doi:10.1371/journal.pone.0005046.s015 (1.36 MB
MOV)
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